Stocks › CMRX

CMRX

CMRX·USD
—
No end-of-day price on record
CMRX
CMRX
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CMRXS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of CMRX by members of U.S. Congress · 2 on record
All congressional trades →
PoliticianStockTypeFiledTraded
James B. RenacciJames B. RenacciHouse · R · OH CMRXCMRX · Stock Sale
$1,001 - $15,000
Dec 21, 2015 Dec 9, 2015 Filing ↗
James B. RenacciJames B. RenacciHouse · R · OH CMRXCMRX · Stock Purchase
$15,001 - $50,000
Feb 10, 2015 Jan 28, 2015 Filing ↗

Whale Activity

Position changes in CMRX reported for 2025-09-30 by 1 institutional filer
Closed: 1
  • Increased0
  • New0
  • Held0
  • Decreased0
  • Closed1
  • No prior filing0
FilerSharesValueChange
Koshinski Asset Management, Inc.0$0closed

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by CMRX insiders, by quarter · Form 4
-25.0K-12.5K012.5K25.0K2025 Q1: -20.8K2025 Q12025 Q2: 02025 Q22025 Q3: 02025 Q32025 Q4: 02025 Q42026 Q1: 02026 Q12026 Q2: 02026 Q22026 Q3: 02026 Q32026 Q4: 02026 Q4

Recent Insider Transactions

407 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Sherman Michael A.Chief Executive Officer · Director Disposition to issuer −233.4K $8.55 $2.0M Apr 21, 2025 Form 4 ↗
Sherman Michael A.Chief Executive Officer · Director Disposition to issuer −103.0K $8.55 $881K Apr 21, 2025 Form 4 ↗
Sherman Michael A.Chief Executive Officer · Director Disposition to issuer −87.0K $8.55 $744K Apr 21, 2025 Form 4 ↗
Riga Thomas JCOO and CCO Disposition to issuer −60.8K $8.55 $520K Apr 21, 2025 Form 4 ↗
MIDDLETON FRED ADirector Disposition to issuer −207.5K $8.55 $1.8M Apr 21, 2025 Form 4 ↗
MIDDLETON FRED ADirector Disposition to issuer −531.9K $8.55 $4.5M Apr 21, 2025 Form 4 ↗
MIDDLETON FRED ADirector Disposition to issuer −2.8M $8.55 $23.7M Apr 21, 2025 Form 4 ↗
MIDDLETON FRED ADirector Disposition to issuer −60.0K $8.55 $513K Apr 21, 2025 Form 4 ↗
MIDDLETON FRED ADirector Disposition to issuer −40.0K $8.55 $342K Apr 21, 2025 Form 4 ↗
Meyer Robert J.Director Disposition to issuer −35.1K $8.55 $301K Apr 21, 2025 Form 4 ↗
Melemed Allen S.CHIEF MEDICAL OFFICER Disposition to issuer −173.9K $8.55 $1.5M Apr 21, 2025 Form 4 ↗
LaSpaluto MichelleCHIEF FINANCIAL OFFICER Disposition to issuer −181.5K $8.55 $1.6M Apr 21, 2025 Form 4 ↗
Jakeman DavidVP OF FINANCE AND ACCOUNTING Disposition to issuer −156.2K $8.55 $1.3M Apr 21, 2025 Form 4 ↗
DEMSKI MARTHA JDirector Disposition to issuer −72.1K $8.55 $616K Apr 21, 2025 Form 4 ↗
Andriole Michael T.PRESIDENT AND CEO · Director Disposition to issuer −630.8K $8.55 $5.4M Apr 21, 2025 Form 4 ↗
Alrutz Michael AlbertSVP AND GENERAL COUNSEL Disposition to issuer −216.7K $8.55 $1.9M Apr 21, 2025 Form 4 ↗
Melemed Allen S.CHIEF MEDICAL OFFICER Sale −3,065 $4.50 $14K Feb 13, 2025 Form 4 ↗
Andriole Michael T.PRESIDENT AND CEO · Director Sale −7,370 $4.52 $33K Feb 13, 2025 Form 4 ↗
Alrutz Michael AlbertSVP AND GENERAL COUNSEL Sale −1,600 $4.52 $7K Feb 13, 2025 Form 4 ↗
Jakeman DavidVP OF FINANCE AND ACCOUNTING Sale −300 $4.53 $1K Feb 13, 2025 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding CMRX · SEC Form N-PORT

No mutual fund or ETF has reported CMRX in an N-PORT filing in the last seven months.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings

No 13D/13G beneficial-ownership filings on record.

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming CMRX as client

No lobbying filings found naming CMRX as the client.

Government Contracts

Federal awards to CMRX · USAspending

No federal contract awards found for CMRX.

U.S. Patents

Recent USPTO applications naming CMRX

No USPTO patent applications found for CMRX.

Annual Financials

From CMRX's 10-K filings · XBRL

CMRX is not in SEC's company list, so there are no XBRL filings to show.

Stock Splits

Every split and reverse split in the price history

No price history on record for CMRX.

Material Events (8-K)

Corporate events filed with the SEC

No 8-K filings on record.

About CMRX

From SEC EDGAR company records

No company profile on record.